These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14230920)

  • 1. DEVELOPMENT AND PROPERTIES OF MOUSE LEUKEMIA L1210 RESISTANT TO MIRACIL D.
    HIRSCHBERG E; BRINDLE SD; SEMENTE G
    Cancer Res; 1964 Nov; 24():1733-7. PubMed ID: 14230920
    [No Abstract]   [Full Text] [Related]  

  • 2. BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
    BROCKMAN RW; ANDERSON EP
    Annu Rev Biochem; 1963; 32():463-512. PubMed ID: 14144487
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECTS OF OTHER AGENTS ON THE BIOLOGIC RESPONSES TO VINCALEUKOBLASTINE.
    CUTTS JH
    Biochem Pharmacol; 1964 Mar; 13():421-31. PubMed ID: 14157604
    [No Abstract]   [Full Text] [Related]  

  • 4. UPTAKE OF MIRACIL D BY CELLS OF SENSITIVE AND MIRACIL D-RESISTANT LINES OF MOUSE LEUKEMIA L1210.
    BRINDLE SD; HIRSCHBERG E; GROSS PR
    Cancer Res; 1964 Nov; 24():1738-40. PubMed ID: 14230921
    [No Abstract]   [Full Text] [Related]  

  • 5. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 6. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS.
    GELLHORN A; WAGNER M; RECHLER M; KOREN Z; BENJAMIN W
    Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813
    [No Abstract]   [Full Text] [Related]  

  • 7. THE PHARMACOLOGICAL AND BIOCHEMICAL ACTIVITY OF 4-AMINO-4-DEOXY-10-METHYLPTEROYLASPARTIC ACID.
    MEAD JA; GREENBERG NH; SCHRECKER AW; SEEGER DR; TOMCUFCIK AS
    Biochem Pharmacol; 1965 Feb; 14():105-14. PubMed ID: 14332455
    [No Abstract]   [Full Text] [Related]  

  • 8. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 9. THE INTERCONVERSION OF PURINES BY TUMORS AND THE ACTION OF ANTI-PURINES.
    BALIS ME; SALSER JS
    Acta Unio Int Contra Cancrum; 1964; 20():115-7. PubMed ID: 14151863
    [No Abstract]   [Full Text] [Related]  

  • 10. INHIBITION OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE SYNTHESIS IN NEOPLASTIC CELLS BY PURINES AND ANALOGS.
    BROCKMAN RW; CHUMLEY S
    Biochim Biophys Acta; 1965 Mar; 95():365-79. PubMed ID: 14342531
    [No Abstract]   [Full Text] [Related]  

  • 11. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHEMOTHERAPY OF ADVANCED MOUSE LEUKEMIA L1210: COMPARISON OF METHOTREXATE ALONE AND IN SEQUENTIAL THERAPY.
    VENDITTI JM; GOLDIN A
    Cancer Res; 1964 Sep; 24():1457-60. PubMed ID: 14221802
    [No Abstract]   [Full Text] [Related]  

  • 13. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSEUDOFEEDBACK INHIBITION OF PURINE SYNTHESIS BY 6-MERCAPTOPURINE RIBONUCLEOTIDE AND OTHER PURINE ANALOGUES.
    MCCOLLISTER RJ; GILBERT WR; ASHTON DM; WYNGAARDEN JB
    J Biol Chem; 1964 May; 239():1560-3. PubMed ID: 14189894
    [No Abstract]   [Full Text] [Related]  

  • 15. ON THE SIMILARITY OF DIHYDROFOLATE REDUCTASES FROM AMETHOPTERIN-SENSITIVE AND AMETHOPTERIN-RESISTANT MOUSE LEUKEMIA (L1210) CELLS.
    KASHKET ER; CRAWFORD EJ; FRIEDKIN M; HUMPHREYS SR; GOLDIN A
    Biochemistry; 1964 Dec; 3():1928-31. PubMed ID: 14269312
    [No Abstract]   [Full Text] [Related]  

  • 16. FURTHER OBSERVATIONS OF THE BINDING AND INHIBITION OF DIHYDROFOLIC REDUCTASE BY FOLIC ACID ANTAGONISTS.
    SCHRECKER AW; HUENNEKENS FM
    Biochem Pharmacol; 1964 May; 13():731-42. PubMed ID: 14181276
    [No Abstract]   [Full Text] [Related]  

  • 17. CONVERSION OF FOLIC ACID DERIVATIVES TO THEIR CONJUGATED FORMS BY CELLS OF STREPTOCOCCUS FAECALIS.
    WOOD RC; WISE MF
    Tex Rep Biol Med; 1965; 23():512-29. PubMed ID: 14336934
    [No Abstract]   [Full Text] [Related]  

  • 18. THERAPEUTIC AND IMMUNOLOGICAL RESPONSE OF MICE WITH MENINGEAL LEUKEMIA (L1210) TO CHALLENGE WITH AN ANTIFOLIC-RESISTANT VARIANT.
    CHIRIGOS MA; THOMAS LB; HUMPHREYS SR; GLYNN JP; GOLDIN A
    Cancer Res; 1964 Apr; 24():409-15. PubMed ID: 14147814
    [No Abstract]   [Full Text] [Related]  

  • 19. THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
    EVANS JS; MUSSER EA; BOSTWICK L; MENGEL GD
    Cancer Res; 1964 Aug; 24():1285-93. PubMed ID: 14216163
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine.
    Nelson JA; Carpenter JW; Rose LM; Adamson DJ
    Cancer Res; 1975 Oct; 35(10):2872-8. PubMed ID: 1157053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.